無錫福祈(qi)制藥有限公(gong)司(si)，前身為(wei)無錫市第二制藥廠，為(wei)江蘇(su)(su)省(sheng)高新(xin)技術企(qi)業(ye)和江蘇(su)(su)省(sheng)科技創新(xin)型企(qi)業(ye), 始建(jian)于(yu)1943年，位于(yu)風景(jing)秀美的(de)太湖之濱。公(gong)司(si)注冊(ce)資本(ben)32000萬元(yuan)人民幣，占地面積100,000平方(fang)米(mi)。公(gong)司(si)主要生(sheng)產抗生(sheng)素原(yuan)料藥、化學合成原(yuan)料藥以及口服固體制劑；發酵總量近500立方(fang)米(mi)，建(jian)有8個符(fu)合國內國際GMP要求(qiu)的(de)生(sheng)產車間。
無(wu)錫(xi)福祈(qi)制藥有限公(gong)司秉承“祈(qi)康厚(hou)生(sheng)(sheng)，福澤民(min)眾”的信念宗(zong)旨，致力于原(yuan)料藥和成品藥研發和生(sheng)(sheng)產，為客戶提供更(geng)好的產品與服務。公(gong)司質量管理(li)體系完善，設備儀(yi)器先進，產品質量優(you)良(liang)，配套設施完善。公(gong)司通過(guo)了由國內外(wai)藥(yao)品監督管(guan)理機關(guan)組織中(zhong)囯GMP（2010）及歐(ou)洲GMP認(ren)證(zheng)，通過(guo)了清潔生(sheng)產審核以及中(zhong)經(jing)科環基于GB/T24001-2016 idt ISO14001：2015 標(biao)(biao)準(zhun)的環境(jing)管(guan)理體系認(ren)證(zheng)；GB/T45001-2020 idt ISO45001：2018 標(biao)(biao)準(zhun)的職業(ye)健康安(an)全管(guan)理體系認(ren)證(zheng)。
公司擁有一大(da)批(pi)高(gao)技術專業人(ren)士(shi)組成的(de)人(ren)才(cai)隊伍，從事著管理、科研(yan)、開發、生(sheng)產、營銷(xiao)工(gong)作。
企(qi)業目(mu)前主要產品有硫(liu)酸(suan)奈替米星，硫(liu)酸(suan)西(xi)索(suo)米星，硫(liu)酸(suan)核糖(tang)霉素及(ji)螺(luo)旋霉素等抗(kang)(kang)(kang)(kang)生素藥(yao)物(wu)，嗎替麥(mai)考酚(fen)酯，他克莫司等器官(guan)移植(zhi)抗(kang)(kang)(kang)(kang)排斥(chi)(chi)方面(mian)的(de)(de)(de)藥(yao)物(wu)，產品遠銷歐洲(zhou)，美洲(zhou)，非洲(zhou)，及(ji)東南亞等幾十個國家和地(di)區。得天(tian)獨厚(hou)的(de)(de)(de)先天(tian)優勢，造(zao)就了(le)企(qi)業深(shen)厚(hou)的(de)(de)(de)文化底蘊；雄厚(hou)的(de)(de)(de)科學技術力(li)量，為企(qi)業的(de)(de)(de)長足(zu)發(fa)(fa)展(zhan)創造(zao)了(le)機(ji)遇(yu)。在以質量求(qiu)生存，以創新(xin)謀發(fa)(fa)展(zhan)的(de)(de)(de)經營(ying)理念的(de)(de)(de)指導下，無錫福祈積極(ji)開發(fa)(fa)治療(liao)器官(guan)移植(zhi)抗(kang)(kang)(kang)(kang)排斥(chi)(chi)藥(yao)，新(xin)型抗(kang)(kang)(kang)(kang)腫瘤藥(yao)以及(ji)保肝藥(yao)等一系列的(de)(de)(de)新(xin)產品，并(bing)逐(zhu)漸穩步拓展(zhan)成(cheng)品藥(yao)市場，為企(qi)業中長期的(de)(de)(de)發(fa)(fa)展(zhan)提供持久動力(li)。
強大的(de)研(yan)發實(shi)力(li)，堅實(shi)的(de)生(sheng)產(chan)技術(shu)，先進的(de)管理(li)理(li)念，創新的(de)經(jing)營思路和(he)不斷(duan)自我提升的(de)質量管理(li)體系是(shi)無錫(xi)福祈的(de)競爭優勢，企業正(zheng)努(nu)力(li)把自身建設成為國內外知(zhi)名的(de)現代化制藥(yao)企業。
WuxiFortune Pharmaceutical co., LTD is formerly known as Wuxi No. 2 Pharmaceutical Factory, is an new high-tech enterprise and technological innovation-based enterprise in Jiangsu Province. It was established in 1943 and located nearby the beautiful Taihu Lake. The registered capital is 320,000,000 RMB, and the total area is 100,000 m2. The main products are antibiotic APIs, chemical synthesis APIs and oral solid preparations. The total fermentation amount is about 500m3. There are eight workshops complied with the requirements of Current Chinese GMP (2010 version), which is equal to that of EU GMP, WHO GMP and ICH Q7A.
Wuxi Fortune pharmaceutical Co., LTD., adheres to the belief of "pray for the health, improve the living condition, bless the people", devotes to developing and manufacturing API and finished products, and provide better products and services. We have complete quality assurance system, advanced facility, providing good products, and perfect matching facilities. The company has passed the Chinese GMP (2010) Certification and European GMP Certification conducted by domestic and foreign regulatory administration authorities, cleaning production audit, the Environmental Management System Certification (GB/T24001-2016/ISO ISO14001:2015), and the Occupational Health and Safety Management System Certification (GB/T45001-2020/ISO 45001:2018) conducted by Beijing Zhongjing Quality Certification Co., Ltd.
At present, the main products are antibiotics drugs such as Netilmicin Sulfate, Sisomicin Sulfate, Ribostamycin Sulfate, and Spiramycin etc. and immunosuppressant like Mycophenolate Mofetiland Tacrolimus. Most of our products are exported to Europe, America, Africa, and Southeast Asia.
The advantagedsuperiority creates deep enterprise culture and the abundant science and technology strength create the development opportunities. Now Wuxi Fortune develops on the organ transplantation anti-rejection drugs, new antineoplastic and hepatoprotective. We also gradually expand the market of finished drug products to provide enduring power for the enterprise development. Strong research and development strength, firm production technology, advanced management ideas, innovative business ideas and continuous self-improvement quality management system are our competitive advantage. We work hard to make the enterprise become a famous modern pharmaceutical enterprise.
